Desirée Kanters’ favorite quote is “we can do this”. Her passion, loyalty and dedication have proven to make complex projects achievable within the set scenery.

Desirée Kanters, managing director, brings to Biop over 20 years of drug development and clinical operations experience in the pharmaceutical, biotech, CRO and consultancy business.

She has built her career in clinical research by at first joining a CRO (SGS) as an employee, to further on provide consultancy, since 2007, to CRO, leading pharmaceutical companies as well as the biotech industry (Johnson & Johnson, Astellas, Galapagos, Movetis, Highlight Therapeutics, Rejuvenate Biomed, PRA, ICON and many more). From her special interest in setting up, managing and following up on complex study designs she specialized herself in start-ups and small-to mid-sized biotech companies during the last years.

Next to overall project management, she gained experience in a broad range of therapeutic areas as well as orphan diseases. She has a wide network and knows what it takes to successfully run clinical studies from phase 0 – IV, leading to drug registration. Her domains of expertise within Clinical Operations are planning and coordination of multiple projects, people and time management, feasibility, vendor and site selection, and budget management.

With efficiency as her favorite word and her ability to think out of the box she sees Biop as her next level and will support the Biop team in making projects achievable within acceptable budget and timelines at high quality standards.

the companies we served: